Arcoma AB

Then we say hello and welcome to Carnegie and today's report interview. My name is Hjalmar and I work as an analyst. Today I have with me Mattias Leire, who is the CEO of Arcoma. Welcome, Mattias. Thank you so much for being here. You released your report last week, so we're going to dive into it. I thought if we start with the gross margin. It is quite strongly strengthened year over year and we know that the market mix is important here. What other factors play into the strong gross margin you have? I'm thinking product mix and pricing and so on.

We have received good reviews of our premium products. We see which one has paid. We are convinced that we have been careful in the business we take. We see that the i3 we released has started to have a good effect and is appreciated by the market. And we see that it plus a number of options for good. So it's a combination, but we're more careful and we're looking to increase profitability and push in low-marginal markets where we focus on those segments where there is profitability.

When you say that you choose marginally strong businesses, can we see it as a shift to how it was 12 months ago? Are you prioritizing more profitable businesses now?